@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_head { this: np:hasAssertion dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_assertion; np:hasProvenance dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_provenance; np:hasPublicationInfo dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_publicationInfo; a np:Nanopublication . dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_assertion a np:Assertion . dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_provenance a np:Provenance . dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_publicationInfo a np:PublicationInfo . } dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_assertion { miriam-gene:4916 a ncit:C16612 . lld:C0006142 a ncit:C7057 . dgn-gda:DGN1369ba30ecb9da4d0a6c26b440a13cde sio:SIO_000628 miriam-gene:4916, lld:C0006142; a sio:SIO_001122 . } dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_provenance { dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_assertion dcterms:description "[To demonstrate the reliability of the probes generated with this protocol, four strategies were employed: (i) probes mapping to cyclin D1 (CCND1) were generated and their performance was compared with that of a commercially available probe for the same gene in a series of 10 FFPETS of breast cancer samples of which five harboured CCND1 amplification; (ii) probes targeting cyclin-dependent kinase 4 were used to validate an amplification identified by microarray-based comparative genomic hybridization (aCGH) in a pleomorphic adenoma; (iii) probes targeting fibroblast growth factor receptor 1 and CCND1 were used to validate amplifications mapping to these regions, as defined by aCGH, in an invasive lobular breast carcinoma with FISH and CISH; and (iv) gene-specific probes for ETV6 and NTRK3 were used to demonstrate the presence of t(12;15)(p12;q25) translocation in a case of breast secretory carcinoma with dual colour FISH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:16446704; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP533617.RAy6A93MY65lqHWpsF9d2fj-C84l-bvFQO4Hjp3eQqTLs130_publicationInfo { this: dcterms:created "2016-05-13T12:45:46+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }